The Board of Navin Fluorine Advanced Sciences Ltd, subsidiary of Navin Fluorine International Ltd, has, approved a capital expenditure of ₹450 crores for setting up a new 40,000 tonnes per annum hydrofluoric acid capacity at Dahej.
Navin Fluorine Advanced Sciences Ltd s Multi-Purpose Plant in Dahej, Gujarat, has commenced commercial production post successful supply of commercial trials to the respective customers.
Maintain ADD on Navin Fluorine International - High-value business aids growth - HDFC Securities equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
HUL, BPCL and Sun Pharma among 10 stocks that could give up to 30% upside
Exide Industries, KPR Mill, BPCL, Sun Pharmaceutical and Maruti Suzuki are also among the 10 stocks December 26, 2020 / 11:46 AM IST After a freefall in the December 21 session, market recovered sharply but ended on flat note for the week ended December 24. BSE Sensex added 12.85 points to end at 46,973.54 and the Nifty50 was down 11.3 points to finish at 13,749.25 levels in the week gone by. HUL | Brokerage: Motilal Oswal | Rating: Buy | LTP: Rs 2,399.95 | Target: Rs 2,750 | Upside: 14 percent. The Broking house remains positive on the company from a medium-term perspective, encouraged by robust earnings growth potential beyond the near term owing to its portfolio and execution strengths and significant synergies in FY22E as a result of GSKCH. These factors suggest premium multiples are likely to sustain.
Navin Fluorine International - Company Update - ICICI Direct
Posted On: 2020-12-17 21:57:44 (Time Zone: Arizona, USA)
Navin Fluorine has outlined capital expenditure for setting up a multi-purpose plant (MPP) with an outlay of Rs. 195 crore. The capex will be undertaken by its wholly owned subsidiary, Navin Fluorine Advanced Sciences Ltd at Dahej, Gujarat. The new capacity is expected to come on stream during H1FY23 and will create opportunities for new products in life science and crop science sectors in the specialty chemicals business. The company has already identified potential 12 new products of which five are going to be commercialised initially, which find application in crop protection. This new capacity would retain a mix of 50:50 among life science and crop protection in the long run. The management expects better margins for this new venture with an asset turn of 1.35-1.45x.